Spector, MD, Duke neurologist, sleep medicine specialist, and author of the recent book Navigating Life with Restless Legs Syndrome
First introduced in early 2024, Mounjaro has gained recognition as an effective GLP-1 & GIP receptor agonist, helping individuals achieve sustainable weight loss
Now researchers are excited about their potential impact on other conditions, including addiction and sleep apnea and even cancer
What are the primary benefits of Semaglutide for weight loss
benefits of incretin-based therapy (GLP-1, GIP)
Furthermore, NAMPT-mediated NAD + biosynthesis and sirtuins in the intestine are critical for intestinal homeostasis, including GLP-1 production [39]